Zhang LX - Search Results

1

Elevated circASCC3 limits antitumor immunity by sponging miR-432-5p to upregulate C5a in non-small cell lung cancer.

Gao J, Zhang LX, Ao YQ, Jin C, Zhang PF, Wang HK, Wang S, Lin M, Jiang JH, Ding JY. Gao J, et al. Among authors: zhang pf, zhang lx. Cancer Lett. 2022 Sep 1;543:215774. doi: 10.1016/j.canlet.2022.215774. Epub 2022 Jun 3. Cancer Lett. 2022. PMID: 35667514

2

The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.

Zhang LX, Gao J, Long X, Zhang PF, Yang X, Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, Lin K, Xu JJ, Wu YB. Zhang LX, et al. Among authors: zhang pf. Mol Cancer. 2022 May 7;21(1):110. doi: 10.1186/s12943-022-01586-w. Mol Cancer. 2022. PMID: 35525959 Free PMC article.

3

Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1.

Gao J, Ao YQ, Zhang LX, Deng J, Wang S, Wang HK, Jiang JH, Ding JY. Gao J, et al. Among authors: zhang lx. J Exp Clin Cancer Res. 2022 Oct 8;41(1):295. doi: 10.1186/s13046-022-02505-z. J Exp Clin Cancer Res. 2022. PMID: 36209117 Free PMC article.

4

TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.

Zhang LX, Yang X, Wu ZB, Liao ZM, Wang DG, Chen SW, Lu F, Wu YB, Zhu SQ. Zhang LX, et al. Cancer Sci. 2023 Mar;114(3):855-869. doi: 10.1111/cas.15668. Epub 2022 Dec 7. Cancer Sci. 2023. PMID: 36403197 Free PMC article.

5

Tumor-infiltrating CD36⁺CD8⁺T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer.

Ao YQ, Gao J, Zhang LX, Deng J, Wang S, Lin M, Wang HK, Ding JY, Jiang JH. Ao YQ, et al. Among authors: zhang lx. BMC Cancer. 2023 Apr 21;23(1):367. doi: 10.1186/s12885-023-10836-z. BMC Cancer. 2023. PMID: 37085798 Free PMC article.

6

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.

Li X, Li J, Xu L, Wei W, Cheng A, Zhang L, Zhang M, Wu G, Cai C. Li X, et al. J Exp Clin Cancer Res. 2022 Apr 21;41(1):149. doi: 10.1186/s13046-022-02362-w. J Exp Clin Cancer Res. 2022. PMID: 35449080 Free PMC article.

7

CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression.

Zhang M, Zhang L, Geng A, Li X, Zhou Y, Xu L, Zeng YA, Li J, Cai C. Zhang M, et al. Cell Rep. 2022 Sep 13;40(11):111331. doi: 10.1016/j.celrep.2022.111331. Cell Rep. 2022. PMID: 36103813 Free article.

8

CDK inhibitors in cancer therapy, an overview of recent development.

Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X, Zheng Q, Cai C. Zhang M, et al. Am J Cancer Res. 2021 May 15;11(5):1913-1935. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094661 Free PMC article. Review.

9

Proteoglycan 4 (Lubricin) and regulation of xanthine oxidase in synovial macrophage as a mechanism of controlling synovitis.

Elsaid KA, Zhang LX, Zhao T, Marks A, Jenkins D, Schmidt TA, Jay GD. Elsaid KA, et al. Among authors: zhang lx. Arthritis Res Ther. 2024 Dec 19;26(1):214. doi: 10.1186/s13075-024-03455-x. Arthritis Res Ther. 2024. PMID: 39696446 Free PMC article.

10

[Clinical observation and anti-drug antibody monitoring of enzyme replacement therapy in children with Fabry disease].

Lu ZH, Shou XY, Lin Q, Zhang LX, Fu HD, Mao JH. Lu ZH, et al. Among authors: zhang lx. Zhonghua Er Ke Za Zhi. 2024 Dec 19;63(1):75-79. doi: 10.3760/cma.j.cn112140-20240711-00478. Online ahead of print. Zhonghua Er Ke Za Zhi. 2024. PMID: 39694566 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

953 results

Search Page

Filters